ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,539,737 | -39.4% | 314,655 | -31.3% | 0.21% | -42.0% |
| Q2 2023 | $14,087,773 | +1303.5% | 458,288 | +1545.0% | 0.37% | +1217.9% |
| Q1 2023 | $1,003,760 | -45.8% | 27,859 | -40.6% | 0.03% | -47.2% |
| Q4 2022 | $1,853,172 | -77.7% | 46,892 | -78.0% | 0.05% | -86.4% |
| Q1 2022 | $8,316,000 | +1053.4% | 213,440 | +1079.6% | 0.39% | +768.9% |
| Q4 2021 | $721,000 | +90.7% | 18,095 | +96.2% | 0.04% | +40.6% |
| Q2 2021 | $378,000 | -72.7% | 9,223 | -71.0% | 0.03% | -74.8% |
| Q1 2021 | $1,386,000 | – | 31,767 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |